International Strategy and Market Performance in New Biotechnology Firms
Regular price
€65.99
14 days return policy
Shipping & Delivery
A01=Joseph E. Coombs
age
Author_Joseph E. Coombs
biotechnology entrepreneurship
Biotechnology Firms
Category=KC
Category=KJ
Ceo Succession
change
Control Variables Model
corporate governance systems
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
Es Si
firm's
Firm's Initial Public Offering
Firm's International Strategy
Firm's Total Assets
Fixed Effects Parameters
foreign
General Covariance Model
initial
International Entrepreneurship
international joint ventures
International Management Literature
International Strategic Change
Lit Er
Multiple Country Studies
Multiple Item Measure
NIH Grant
organizational change management
performance measurement methods
Prior Firm Performance
public
REML Log Likelihood
Resource Commitment
resource-based view
resources
revenue
SAS Institute
SAS Mixed Procedure
slack
Standard Linear Model
strategic adaptation in biotech firms
strategie
Strategie Change
TMT
Product details
- ISBN 9781138972933
- Weight: 453g
- Dimensions: 138 x 216mm
- Publication Date: 26 Oct 2016
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
The issues addressed in this study are: What internal factors support changes in the international operations of new firms? and What effect do these changes have on the firm's structure, control system, and market performance. To answer these questions, this work examines the internal resources and market performance of a set of publicly traded biotechnology firms. Findings support the view that new firms can enter international markets through a variety of strategies, including international joint ventures and subsidiaries. Changes in international operations also are found to enhance firm market performance when accompanied by changes in firm structure and control systems. However, managers must be patient because market performance only improves significantly two years after these organizational changes have taken place.
